Kauppila A, Puukka M, Tuimala R
Am J Obstet Gynecol. 1979 Aug 1;134(7):752-5. doi: 10.1016/0002-9378(79)90941-4.
It is established that PRL secretion is regulated by estrogens. Glucocorticoids, on the other hand, suppress estrogen secretion during pregnancy and may also inhibit PRL by direct hypothalamopituitary action. In this study PRL and estradiol were determined with specific radioimmunoassays in 14 women during gestational weeks 28 to 34 prior to, during, and following short-term intramuscular dexamethasone administration (12, 8, and 4 mg on three consecutive days) used for prophylaxis of RDS in preterm infants. There were no significant alterations in PRL serum concentrations; estradiol showed a significant drop (P less than 0.001) during all 3 days of treatment, returning to the pretreatment level on posttreatment day 1. The PRL and TSH responses to 200 micrograms of intravenous TRH on day 2 or 3 of dexamethasone treatment in six women during late pregnancy were not inhibited. Short-term dexamethasone treatment with pharmacologic doses does not suppress the physiologic secretion and release of PRL or the release induced by TRH during late pregnancy.
现已确定,催乳素(PRL)的分泌受雌激素调节。另一方面,糖皮质激素在孕期会抑制雌激素分泌,还可能通过下丘脑 - 垂体的直接作用抑制PRL。在本研究中,采用特异性放射免疫分析法,对14名孕周在28至34周的女性,在短期肌肉注射地塞米松(连续三天分别注射12毫克、8毫克和4毫克,用于预防早产儿呼吸窘迫综合征)之前、期间及之后,测定PRL和雌二醇水平。PRL血清浓度无显著变化;雌二醇在治疗的三天中均显著下降(P小于0.001),在治疗后第1天恢复到治疗前水平。对6名晚期妊娠女性在接受地塞米松治疗的第2天或第3天静脉注射200微克促甲状腺激素释放激素(TRH)后,PRL和促甲状腺激素(TSH)的反应未受抑制。孕期晚期使用药理剂量的短期地塞米松治疗不会抑制PRL的生理性分泌和释放,也不会抑制TRH诱导的PRL释放。